Travella 6C tablets

País: Irlanda

Idioma: anglès

Font: HPRA (Health Products Regulatory Authority)

ingredients actius:

Delphinium staphisagria; Anamirta cocculus; Petroleum rectificatum; Nicotiana tabacum; Strychnos nux-vomica

Disponible des:

A. Nelson & Company Limited

Designació comuna internacional (DCI):

Delphinium staphisagria; Anamirta cocculus; Petroleum rectificatum; Nicotiana tabacum; Strychnos nux-vomica

Dosis:

6C

formulario farmacéutico:

Tablet

Estat d'Autorització:

Marketed

Data d'autorització:

2020-12-18

Informació per a l'usuari

_ _
1.3.1 Packaging leaflet
Created date: 09/11/20
_Confidential _
HOA 1149/004/001 Travella
Page 1 of 3
1.3
PRODUCT INFORMATION
1.3.1
PACKAGE LEAFLET
PARTICULARS TO APPEAR ON THE PACKAGE LEAFLET
PACKAGE LEAFLET
A Homeopathic Medicinal Product
Travella 6C tablets
Anamirta cocculus 6C
Delphinium staphisagria 6C
Nicotiana tabacum 6C
Petroleum rectificatum 6C
Strychnos nux-vomica 6C
PLEASE READ ALL OF THIS LEAFLET CAREFULLY BEFORE TAKING THIS MEDICINE,
IT CONTAINS
IMPORTANT INFORMATION.
KEEP THIS LEAFLET; YOU MIGHT NEED TO READ IT AGAIN.
1. WHAT IS THIS MEDICINE FOR
Travella is a homeopathic medicinal product used within the
homeopathic tradition
for the relief of symptoms of travel sickness, such as nausea,
vomiting, dizziness
and headache.
2. BEFORE TAKING THIS MEDICINE
• Do not take this medicine if you are under 12 years old.
• Do not take this medicine if you are allergic to any of the
ingredients, see section 6.
• This product contains lactose and sucrose. If you have been told
by your doctor
that you have an intolerance to some sugars, consult your doctor
before taking this
medicine.
• Talk to your doctor or pharmacist before taking this medicine if
you are:
- taking any other medicines, including those bought without a
prescription.
- pregnant or breastfeeding.
3. HOW TO USE THIS MEDICINE
FOR ORAL USE
ADULTS, THE ELDERLY AND CHILDREN OVER 12 YEARS
DIRECTIONS
Take 2 tablets every hour for 2 hours before the journey. Take 2
tablets hourly during
the journey if necessary.
Tablets to be sucked or chewed.
If symptoms worsen, or persist after 5 days, consult your doctor or
qualified
healthcare practitioner.
_ _
1.3.1 Packaging leaflet
Created date: 09/11/20
_Confidential _
HOA 1149/004/001 Travella
Page 2 of 3
DO NOT exceed the stated dose.
IF YOU FORGET TO TAKE THIS MEDICINE, continue with the usual dose at
the usual time.
It does not matter if you have missed a dose. Do not take a double
dose to make up
for a missed dose.
IF YOU TAKE TOO MUCH OF THIS MEDICINE speak to a doctor or pharmacist
and take
this

Fitxa tècnica

Health Products Regulatory Authority
18 December 2020
CRN008K7X
Page 1 of 3
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Travella 6C tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
Anamirta cocculus 6C
Delphinium staphisagria 6C
Nicotiana tabacum 6C
Petroleum rectificatum 6C
Strychnos nux-vomica 6C
Excipient(s) with known effect:
Lactose 174.26 mg
Sucrose 42.39 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet
Biconvex circular white to off-white tablets
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
A Homeopathic Medicinal product used within the homeopathic tradition
for the relief of symptoms of travel sickness, such as
nausea, vomiting, dizziness and headache.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For oral use
Adults, the elderly and children over 12 years: Take 2 tablets every
hour for 2 hours before the journey. Take 2 tablets hourly
during the journey if necessary.
Tablets to be sucked or chewed.
This product is not recommended for use in children under 12 years of
age.
If the symptoms worsen, or persist after 5 days, a doctor or qualified
healthcare practitioner should be consulted.
4.3 CONTRAINDICATIONS
Hypersensitivity to any of the active ingredients or any of the
excipients.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Do not exceed the stated dose.
This product is not recommended for use in children under 12 years of
age and medical advice should be sought.
If symptoms worsen, or persist after 5 days, a doctor or qualified
healthcare practitioner should be consulted.
Health Products Regulatory Authority
18 December 2020
CRN008K7X
Page 2 of 3
Contains lactose and sucrose - Patients with rare hereditary problems
of fructose intolerance, galactose intolerance, the Lapp
lactase deficiency, glucose-galactose malabsorption or
sucrose-insomaltese insufficiency should not take this medicine.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTIONS
None known
4.6 FERTILITY, PREGNANCY AND LACTATION
Pregn